SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

G— Furthermore, the U.S. Supreme Court held that

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Biobillionair Member Profile
 
Followed By 68
Posts 10,465
Boards Moderated 1
Alias Born 01/12/13
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/6/2017 7:23:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:26:27 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 4:26:02 PM
Amarin and HLS Therapeutics Announce Agreement to Commercialize Vascepa® in Canada "GlobeNewswire Inc." - 9/25/2017 6:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 9/22/2017 1:08:41 PM
Amarin to Present at Cantor Global Healthcare Conference "GlobeNewswire Inc." - 9/20/2017 4:30:00 PM
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer "GlobeNewswire Inc." - 9/13/2017 6:00:00 AM
Amarin to Present at Rodman & Renshaw’s Global Investment Conference "GlobeNewswire Inc." - 9/6/2017 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/30/2017 4:02:36 PM
Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Moni... "GlobeNewswire Inc." - 8/14/2017 6:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/2/2017 5:06:42 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/2/2017 6:38:43 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/2/2017 6:31:46 AM
Amarin Reports Second Quarter 2017 Financial Results and Provides Update on Operations "GlobeNewswire Inc." - 8/2/2017 5:30:00 AM
Amarin to Report Second Quarter 2017 Results and Host Conference Call on August 2, 2017 "GlobeNewswire Inc." - 7/26/2017 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:22:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:22:30 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:22:02 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 7:20:53 PM
Amarin Corporation plc (Nasdaq: AMRN) to Ring The Nasdaq Stock Market Opening Bell "GlobeNewswire Inc." - 6/12/2017 10:00:00 AM
Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2... "GlobeNewswire Inc." - 6/12/2017 7:00:00 AM
Amarin to Present at the Jefferies 2017 Global Healthcare Conference "GlobeNewswire Inc." - 6/1/2017 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/19/2017 9:07:06 AM
Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care "GlobeNewswire Inc." - 5/18/2017 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/17/2017 5:26:59 PM
Biobillionair   Thursday, 10/05/17 10:10:06 PM
Re: HDGabor post# 115609
Post # of 116345 
G—
Quote:
Furthermore, the U.S. Supreme Court held that an agency’s decision not to pursue an enforcement action is presumptively unreviewable, as such actions are “committed to agency discretion by law” under § 701(a)(2) of the Administrative Procedure Act.



The act of not pursuing an enforcement action may be “unreviewable” but the act of ANCHOR SPA & Ad Com REDUCE-IT slander is reviewable. Amarin pursuing “enforcement” is exhausting all administrative actions...exhausting administrative actions is a setup for an all out suit against US Government if failure to act is perceived.
BB


Mr. McGee, don't make me angry. You wouldn't like me when I'm angry---David Banner
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist